当前位置： SCI文献检索 > Journal of the International AIDS Society期刊下所有文献 > Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Abstract：

BACKGROUND:Diagnosis of primary HIV infection (PHI) has important clinical and public health implications. HAART initiation at this stage remains controversial. METHODS:Our objective was to identify predictors of disease progression among Argentinean seroconverters during the first year of infection, within a multicentre registry of PHI-patients diagnosed between 1997 and 2008. Cox regression was used to analyze predictors of progression (LT-CD4 < 350 cells/mm3, B, C events or death) at 12 months among untreated patients. RESULTS:Among 134 subjects, 74% presented with acute retroviral syndrome (ARS). Seven opportunistic infections (one death), nine B events, and 10 non-AIDS defining serious events were observed. Among the 92 untreated patients, 24 (26%) progressed at 12 months versus three (7%) in the treated group (p = 0.01). The 12-month progression rate among untreated patients with ARS was 34% (95% CI 22.5-46.3) versus 13% (95% CI 1.1-24.7) in asymptomatic patients (p = 0.04). In univariate analysis, ARS, baseline LT-CD4 < 350 cells/mm3, and baseline and six-month viral load (VL) > 100,000 copies/mL were associated with progression. In multivariate analysis, only ARS and baseline VL > 100,000 copies/mL remained independently associated; HR: 8.44 (95% CI 0.97-73.42) and 9.44 (95% CI 1.38-64.68), respectively. CONCLUSIONS:In Argentina, PHI is associated with significant morbidity. HAART should be considered in PHI patients with ARS and high baseline VL to prevent disease progression.

journal_name

J Int AIDS Soc

journal_title

Journal of the International AIDS Society

authors

Socías ME,Sued O,Laufer N,Lázaro ME,Mingrone H,Pryluka D,Remondegui C,Figueroa MI,Cesar C,Gun A,Turk G,Bouzas MB,Kavasery R,Krolewiecki A,Pérez H,Salomón H,Cahn P,Grupo Argentino de Seroconversión Study Group.

doi

10.1186/1758-2652-14-40

subject

Has Abstract

pub_date

2011-08-10 00:00:00

pages

40

issn

1758-2652

pii

1758-2652-14-40

journal_volume

14

pub_type

杂志文章

相关文献

Journal of the International AIDS Society文献大全
  • What makes orphans in Kigali, Rwanda, non-adherent to antiretroviral therapy? Perspectives of their caregivers.

    abstract：INTRODUCTION:Every year, approximately 260,000 children are infected with HIV in low- and middle-income countries. The timely initiation and high level of maintenance of antiretroviral therapy (ART) are crucial to reducing the suffering of HIV-positive children. We need to develop a better understanding of the backgrou...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.1.19310

    authors： Kikuchi K,Poudel KC,Muganda J,Sato T,Mutabazi V,Muhayimpundu R,Majyambere A,Nyonsenga SP,Sase E,Jimba M

    更新日期：2014-12-03 00:00:00

  • Treatment as prevention: preparing the way.

    abstract：:Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by reducing viral load and allowing their immune systems to recover. The reduction in viral load soon after starting ART has led to the hypothesis that early and widespread ART could prevent onward transmission and therefore ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1186/1758-2652-14-S1-S6

    authors： Williams B,Wood R,Dukay V,Delva W,Ginsburg D,Hargrove J,Stander M,Sheneberger R,Montaner J,Welte A

    更新日期：2011-07-06 00:00:00

  • Time trends and correlates of late presentation for HIV care in Northern Greece during the decade 2000 to 2010.

    abstract：BACKGROUND:The aim of our study was to assess the extent of late presentation for HIV care in Northern Greece during the period 2000 to 2010 and to explore correlations aiming to provide guidance for future interventions. METHODS:HIV-positive patients with no prior history of HIV care at presentation and with a CD4 T ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.15.2.17395

    authors： Metallidis S,Pilalas D,Skoura L,Haidich AB,Tsachouridou O,Papaioannou M,Chrysanthidis T,Bakaimi I,Antoniadou ZA,Margariti A,Malisiovas N,Nikolaidis P

    更新日期：2012-10-11 00:00:00

  • HIV-1 tat and rev upregulates osteoclast bone resorption.

    abstract：INTRODUCTION:Disruption in bone homeostasis with increased osteoclastic resorption may lead to osteoporosis. HIV tat has been found to increase differentiation of precursor cells into osteoclast (OC) (1). Presence of soluble HIV proteins in virally suppressed HIV patients on ART may drive a bone resorption phenotype. W...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19724

    authors： Chew N,Tan E,Li L,Lim R

    更新日期：2014-11-02 00:00:00

  • Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.

    abstract：INTRODUCTION:Limited data exist on acceptability of candidate pre-exposure prophylaxis (PrEP) regimens among US women. We evaluated PrEP experiences, attitudes and future use intentions among sexually active women who completed the US-based HIV Prevention Trials Network 069/AIDS Clinical Trials Group 5305 study. METHO...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/jia2.25247

    authors： Amico KR,Ramirez C,Caplan MR,Montgomery BE,Stewart J,Hodder S,Swaminathan S,Wang J,Darden-Tabb NY,McCauley M,Mayer KH,Wilkin T,Landovitz RJ,Gulick R,Adimora AA,HPTN 069\/A5305 Study Team and HPTN Women at Risk Committee.

    更新日期：2019-03-01 00:00:00

  • Investigating combination HIV prevention: isolated interventions or complex system.

    abstract：INTRODUCTION:Treatment as prevention has mobilized new opportunities in preventing HIV transmission and has led to bold new UNAIDS targets in testing, treatment coverage and transmission reduction. These will require not only an increase in investment but also a deeper understanding of the dynamics of combining behavio...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.18.1.20499

    authors： Brown G,Reeders D,Dowsett GW,Ellard J,Carman M,Hendry N,Wallace J

    更新日期：2015-12-14 00:00:00

  • Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.

    abstract：INTRODUCTION:Antiretroviral (ARV)-based pre-exposure prophylaxis (PrEP) is a promising new HIV prevention strategy. However, variable levels of adherence have yielded mixed results across several PrEP trials and populations. It is not clear how taking ARV - traditionally used for HIV treatment - is perceived and how th...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,随机对照试验

    doi：10.7448/IAS.17.3.19146

    authors： van der Straten A,Stadler J,Luecke E,Laborde N,Hartmann M,Montgomery ET,VOICE-C Study Team.

    更新日期：2014-09-08 00:00:00

  • Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.

    abstract：INTRODUCTION:T cell immunoglobulin and mucin domain (Tim) 3 and programmed death 1 (PD-1) are co-inhibitory receptors involved in the so-called T cell exhaustion, and in vivo blockade of these molecules restores T cell dysfunction. High expression of Tim-3 and PD-1 is induced after chronic antigen-specific stimulation ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.18.1.20078

    authors： Sada-Ovalle I,Ocaña-Guzman R,Pérez-Patrigeón S,Chávez-Galán L,Sierra-Madero J,Torre-Bouscoulet L,Addo MM

    更新日期：2015-10-19 00:00:00

  • Long-term fat redistribution in ARV-naïve HIV+ patients initiating a non-thymidine containing regimen in clinical practice.

    abstract：INTRODUCTION:Lipodystrophy is still a matter of concern in HIV+ patients receiving ART. However, long-term fat change in patients taking non-thymidine regimens is not well known. MATERIALS AND METHODS:A prospective ongoing fat change assessment including clinical evaluation and dexa scans (Hologic QDR 4500) is being c...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19553

    authors： Ferrer E,Navarro A,Curto J,Medina P,Rozas N,Barrera G,Saumoy M,Tiraboschi JM,Gomez C,Podzamczer D

    更新日期：2014-11-02 00:00:00

  • Index and targeted community-based testing to optimize HIV case finding and ART linkage among men in Zambia.

    abstract：INTRODUCTION:Current healthcare systems fail to provide adequate HIV services to men. In Zambia, 25% of adult men living with HIV were unaware of their HIV status in 2018, and 12% of those who were unaware of their HIV statu were not receiving antiretroviral therapy (ART) due to pervasive barriers to HIV testing servic...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25520

    authors： Mwango LK,Stafford KA,Blanco NC,Lavoie MC,Mujansi M,Nyirongo N,Tembo K,Sakala H,Chipukuma J,Phiri B,Nzangwa C,Mwandila S,Nkwemu KC,Saadani A,Mwila A,Herce ME,Claassen CW

    更新日期：2020-06-01 00:00:00

  • Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy.

    abstract：INTRODUCTION:This descriptive, non-interventional study on HIV-1-infected patients treated with DRV/r in the usual clinical setting, with a single-arm prospective observational design, collected data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in marketing authorization in usual clinica...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19573

    authors： Antinori A,Borderi M,Cauda R,Bini T,Chirianni A,Squillace N,Mancusi D,Termini R

    更新日期：2014-11-02 00:00:00

  • Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa.

    abstract：INTRODUCTION:Although hepatitis C virus (HCV) screening is recommended for all HIV-infected patients initiating antiretroviral therapy, data on epidemiologic characteristics of HCV infection in resource-limited settings are scarce. METHODS:We searched PubMed and EMBASE for studies assessing the prevalence of HCV infec...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,meta分析,评审

    doi：10.7448/IAS.19.1.20711

    authors： Azevedo TC,Zwahlen M,Rauch A,Egger M,Wandeler G

    更新日期：2016-06-09 00:00:00

  • Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.

    abstract：INTRODUCTION:Modern combined antiretroviral therapies (cART) allow to effectively suppress HIV-1 viral load, with the 90% virologic success rate, meeting the WHO target in most clinical settings. The aim of this study was to analyse antiretroviral treatment efficacy in Poland and to identify variables associated with v...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.20.1.21847

    authors： Parczewski M,Siwak E,Leszczyszyn-Pynka M,Cielniak I,Burkacka E,Pulik P,Witor A,Muller K,Zasik E,Grzeszczuk A,Jankowska M,Lemańska M,Olczak A,Grąbczewska E,Szymczak A,Gąsiorowski J,Szetela B,Bociąga-Jasik M,Skwara P,

    更新日期：2017-07-17 00:00:00

  • PrEP uptake preferences among men who have sex with men in China: results from a National Internet Survey.

    abstract：INTRODUCTION:HIV incidence among men who have sex with men (MSM) is high in China. Pre-exposure prophylaxis (PrEP) is a promising mean to prevent HIV transmission but it is not widely available in China. We conducted a large Internet-based online survey to assess the willingness of Chinese MSM to take PrEP and associat...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25242

    authors： Han J,Bouey JZ,Wang L,Mi G,Chen Z,He Y,Viviani T,Zhang F

    更新日期：2019-02-01 00:00:00

  • Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo.

    abstract：INTRODUCTION:The majority of new HIV infections occur through mucosal transmission. The availability of readily applicable and accessible platforms for anti-retroviral (ARV) delivery is critical for the prevention of HIV acquisition through sexual transmission in both women and men. There is a compelling need for devel...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25628

    authors： Crakes KR,Herrera C,Morgan JL,Olstad K,Hessell AJ,Ziprin P,LiWang PJ,Dandekar S

    更新日期：2020-10-01 00:00:00

  • WHO guidance grounded in a comprehensive approach to sexual and reproductive health and human rights: topical pre-exposure prophylaxis.

    abstract：INTRODUCTION:Two new microbicide products based on topical (vaginal) application of antiretroviral drugs - 1% tenofovir gel and the dapivirine ring - are currently in late-stage clinical testing, and results on their safety and effectiveness are expected to become available in early 2015. WHO guidelines on the use of t...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.3.19279

    authors： Lusti-Narasimhan M,Khosla R,Baggaley R,Temmerman M,McGrory E,Farley T

    更新日期：2014-09-08 00:00:00

  • Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.

    abstract：INTRODUCTION:Lopinavir/ritonavir-based antiretroviral therapy (ART) is recommended for all HIV-infected children less than three years. However, little is known about its field implementation and effectiveness in West Africa. We assessed the 12-month response to lopinavir/ritonavir-based antiretroviral therapy in a coh...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.20.01.21362

    authors： Amani-Bosse C,Dahourou DL,Malateste K,Amorissani-Folquet M,Coulibaly M,Dattez S,Emieme A,Barry M,Rouzioux C,N'gbeche S,Yonaba C,Timité-Konan M,Mea V,Ouédraogo S,Blanche S,Meda N,Seguin-Devaux C,Leroy V

    更新日期：2017-04-25 00:00:00

  • Improvements in the South African HIV care cascade: findings on 90-90-90 targets from successive population-representative surveys in North West Province.

    abstract：INTRODUCTION:To achieve epidemic control of HIV by 2030, countries aim to meet 90-90-90 targets to increase knowledge of HIV-positive status, initiation of antiretroviral therapy (ART) and viral suppression by 2020. We assessed the progress towards these targets from 2014 to 2016 in South Africa as expanded treatment p...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25295

    authors： Lippman SA,El Ayadi AM,Grignon JS,Puren A,Liegler T,Venter WDF,Ratlhagana MJ,Morris JL,Naidoo E,Agnew E,Barnhart S,Shade SB

    更新日期：2019-06-01 00:00:00

  • Prisoners co-infected with tuberculosis and HIV: a systematic review.

    abstract：INTRODUCTION:Almost from the beginning of the HIV epidemic in 1981, an association with tuberculosis (TB) was recognized. This association between HIV and TB co-infection has been particularly evident amongst prisoners. However, despite this, few studies of TB in prisons have stratified results by HIV status. Given the...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,评审

    doi：10.7448/IAS.19.1.20960

    authors： Edge CL,King EJ,Dolan K,McKee M

    更新日期：2016-11-15 00:00:00

  • Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc.

    abstract：INTRODUCTION:Cenicriviroc (CVC), a once-daily, dual CCR5/CCR2 co-receptor antagonist, has completed Phase 2b development. CVC demonstrated favourable safety and similar efficacy compared with efavirenz (EFV) in Study 202 (NCT01338883); an ex vivo sub-analysis evaluated treatment effects on HIV entry, measured by intrac...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19531

    authors： Kramer V,Hassounah S,Colby-Germinario S,Mesplède T,Lefebvre E,Wainberg M

    更新日期：2014-11-02 00:00:00

  • High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.

    abstract：INTRODUCTION:Pre-treatment HIV drug resistance (PDR) is an increasing problem in sub-Saharan Africa. Children are an especially vulnerable population to develop PDR given that paediatric second-line treatment options are limited. Although monitoring of PDR is important, data on the paediatric prevalence in sub-Saharan ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.19.1.21140

    authors： Boerma RS,Boender TS,Sigaloff KC,Rinke de Wit TF,van Hensbroek MB,Ndembi N,Adeyemo T,Temiye EO,Osibogun A,Ondoa P,Calis JC,Akanmu AS

    更新日期：2016-11-10 00:00:00

  • The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV.

    abstract：INTRODUCTION:Cardiovascular disease (CVD) is the leading cause of death in England and Wales. As people living with HIV (PLWH) age, proactive management of CVD risk factors is crucial. The long-awaited draft guidelines for CVD from the National Institute of Clinical Excellence (NICE) propose lipid modification (with st...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19713

    authors： Ahmed N,Bradley S,Pearson P,Edwards S,Waters L

    更新日期：2014-11-02 00:00:00

  • The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV.

    abstract：INTRODUCTION:Most clinical trials for new antiretroviral (ARV) agents are conducted among narrowly defined adult populations. Only after safety and efficacy have been clearly demonstrated among adults living with HIV are trials including adolescents, children and infants conducted. This approach contributes to signific...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25576

    authors： Rojo P,Carpenter D,Venter F,Turkova A,Penazzato M

    更新日期：2020-09-01 00:00:00

  • Addressing treatment and care needs of older adults living with HIV who use drugs.

    abstract：INTRODUCTION:Older adults living with HIV (OALHIV; ≥50 years) who use drugs face unique needs and challenges that compromise their health and wellbeing due to the structural and environmental barriers they experience, in addition to being disproportionately affected by comorbidities. Nevertheless, research on this popu...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25577

    authors： Chayama KL,Ng C,McNeil R

    更新日期：2020-08-01 00:00:00

  • Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.

    abstract：BACKGROUND:This retrospective survey describes types of cancers diagnosed in HIV-infected subjects in Asia, and assesses risk factors for cancer in HIV-infected subjects using contemporaneous HIV-infected controls without cancer. METHODS:TREAT Asia HIV Observational Database (TAHOD) sites retrospectively reviewed clin...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1186/1758-2652-13-51

    authors： Petoumenos K,Hui E,Kumarasamy N,Kerr SJ,Choi JY,Chen YM,Merati T,Zhang F,Lim PL,Sungkanuparph S,Pujari S,Ponnampalavanar S,Ditangco R,Lee CK,Grulich A,Law MG,TREAT Asia HIV Observational Database.

    更新日期：2010-12-10 00:00:00

  • Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa.

    abstract：INTRODUCTION:There is great interest for integrating care for non-communicable diseases (NCDs) into routine HIV services in sub-Saharan Africa (SSA) due to the steady rise of the number of people who are ageing with HIV. Suggested health system approaches for intervening on these comorbidities have mostly been normativ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25508

    authors： Kintu A,Sando D,Okello S,Mutungi G,Guwatudde D,Menzies NA,Danaei G,Verguet S

    更新日期：2020-06-01 00:00:00

  • Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.

    abstract：INTRODUCTION:Infection with HIV subtype A has been associated with poorer neurocognitive outcomes compared to HIV subtype D in Ugandan children not eligible for antiretroviral therapy (ART). In this study, we sought to determine whether subtype-specific differences are also observed among children receiving ART. MATER...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/jia2.25015

    authors： Bangirana P,Ruel TD,Boivin MJ,Pillai SK,Giron LB,Sikorskii A,Banik A,Achan J

    更新日期：2017-10-01 00:00:00

  • Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.

    abstract：INTRODUCTION:Women in sub-Saharan Africa spend a substantial portion of their reproductive lives pregnant and/or breastfeeding (P/BF), yet they have limited options to prevent HIV during these maternal stages. In preparation for phase 3b prevention trials in P/BF women, we explored attitudes about using a vaginal ring ...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.1002/jia2.25536

    authors： van der Straten A,Ryan JH,Reddy K,Etima J,Taulo F,Mutero P,Taylor J,Piper J,Musara P,MTN-041\/MAMMA Study Team.

    更新日期：2020-06-01 00:00:00

  • Transactional sex and risk for HIV infection in sub-Saharan Africa: a systematic review and meta-analysis.

    abstract：INTRODUCTION:Young women aged 15 to 24 years in sub-Saharan Africa continue to be disproportionately affected by HIV. A growing number of studies have suggested that the practice of transactional sex may in part explain women's heightened risk, but evidence on the association between transactional sex and HIV has not y...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章,meta分析,评审

    doi：10.7448/IAS.19.1.20992

    authors： Wamoyi J,Stobeanau K,Bobrova N,Abramsky T,Watts C

    更新日期：2016-11-02 00:00:00

  • Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study.

    abstract：INTRODUCTION:The 48-week interim analysis of the MODAT study showed that confirmed virologic failure (CVF) was more frequent in patients simplifying to ATV/r monotherapy compared to maintaining ATV/r-based triple therapy. The DSMB recommended stopping study enrollment but continuing follow-up of enrolled patients. We p...

    journal_title：Journal of the International AIDS Society

    pub_type： 杂志文章

    doi：10.7448/IAS.17.4.19806

    authors： Spagnuolo V,Galli L,Bigoloni A,Nozza S,Monforte Ad,Antinori A,Di Biagio A,Rusconi S,Guaraldi G,Di Giambenedetto S,Lazzarin A,Castagna A

    更新日期：2014-11-02 00:00:00